Literature DB >> 19356275

Actual cost of providing long-acting reversible contraception: a study of Implanon cost.

Clare Lipetz1, Ceri Phillips, Charlotte Fleming.   

Abstract

BACKGROUND: The National Institute for Health and Clinical Excellence (NICE) has judged Implanon to be the most cost effective of the long-acting reversible contraception (LARC) methods, and its cost effectiveness is enhanced with increased duration of use. Gwent Sexual and Reproductive Health service provides unrestricted use of Implanon, and with the number of implants fitted increasing annually the service wanted to know how long clients were keeping their contraceptive implants in and the cost of implant provision.
METHODS: The actual cost of providing Implanon was calculated in a cohort of 493 patients within a community-based sexual and reproductive health service, and compared to that predicted in the NICE Clinical Guideline 30 on LARC.
RESULTS: The annual cost for the method (using Implanon) was pound77.49, 25% lower than the estimate made by NICE, despite a shorter duration of use of the method.
CONCLUSION: The actual cost in this community-based sexual and reproductive health service may not be transferable to other settings such as general practice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19356275     DOI: 10.1783/147118909787931555

Source DB:  PubMed          Journal:  J Fam Plann Reprod Health Care        ISSN: 1471-1893


  3 in total

Review 1.  Contraceptive failure in the United States.

Authors:  James Trussell
Journal:  Contraception       Date:  2011-03-12       Impact factor: 3.375

2.  Demand for long acting contraceptive methods and associated factors among family planning service users, Northwest Ethiopia: a health facility based cross sectional study.

Authors:  Saleamlak Adbaru Yalew; Berihun Megabiaw Zeleke; Alemayehu Shimeka Teferra
Journal:  BMC Res Notes       Date:  2015-02-04

3.  Factors influencing use of long-acting versus short-acting contraceptive methods among reproductive-age women in a resource-limited setting.

Authors:  Leevan Tibaijuka; Robert Odongo; Emma Welikhe; Wilber Mukisa; Lilian Kugonza; Imelda Busingye; Phelomena Nabukalu; Joseph Ngonzi; Stephen B Asiimwe; Francis Bajunirwe
Journal:  BMC Womens Health       Date:  2017-04-04       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.